Synthesis of Sphingosine Kinase Inhibitors and Its Anticancer Activity in Pancreatic Cancer Cells

被引：0
|
作者：
Park, Eun-Young [1 ]
Baek, Dong Jae [1 ]
机构：
[1] College of Pharmacy, Mokpo National University, Jeonnam, 58554, Korea, Republic of
来源：
Journal of the Korean Chemical Society | 2022年 / 66卷 / 02期
关键词：
D O I：
10.5012/jkcs.2022.66.2.171
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 175
相关论文
共 50 条
  • [21] Synthesis of Sphingosine Kinase 1 Inhibitors with Modifications of Zone 2
    Nemeth, Ansley
    Grattan, T. Christian
    FASEB JOURNAL, 2017, 31
  • [22] Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors
    Shakeel, Ilma
    Haider, Shaista
    Khan, Shama
    Ahmed, Shahbaz
    Hussain, Afzal
    Alajmi, Mohamed F.
    Chakrabarty, Anindita
    Afzal, Mohammad
    Hassan, Md. Imtaiyaz
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [23] Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules
    Pyne, Susan
    Bittman, Robert
    Pyne, Nigel J.
    CANCER RESEARCH, 2011, 71 (21) : 6576 - 6582
  • [24] Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors
    Olgen, Sureyya
    Kaleli, Sevde Nur Biltekin
    Karaca, Banu Taktak
    Demirel, Ural U.
    Bristow, Hacer Karatas
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (24) : 3798 - 3817
  • [25] Sphingosine kinase activity and sphingosine-1 phosphate production in rat pancreatic islets and INS-1 cells - Response to cytokines
    Mastrandrea, LD
    Sessanna, SM
    Laychock, SG
    DIABETES, 2005, 54 (05) : 1429 - 1436
  • [26] Design, synthesis, and structure-activity relationship studies of phthalimide-based sphingosine kinase inhibitors
    Afrin, Farjana
    Obuch, Katherine
    Kharel, Yugesh
    Santos, Webster L.
    Lynch, Kevin R.
    Pashikanti, Srinath
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [27] Design and synthesis of Aurora kinase inhibitors as anticancer agents
    Hsu, Yung Chang
    Shiao, Hui-Yi
    Lin, Wen-Hsing
    Hsu, John Tsu-An
    Chen, Chiung-Tong
    Chao, Yu-Sheng
    Hsieh, Hsing-Pang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [28] KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity
    Liu, Xu
    Guo, Xiao-Zhong
    Zhang, Wei-Wei
    Lu, Zhuo-Zhuang
    Zhang, Qun-Wei
    Duan, Hai-Feng
    Wang, Li-Sheng
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (02) : 201 - 208
  • [29] Development of FUBP1 inhibitors to reprogram pancreatic cancer cells into an anticancer phenotype
    Bunea, Alexandra
    Polera, Christopher
    Dobrovolskaite, Aiste
    Moots, Holly
    Phanstiel, Otto
    CANCER RESEARCH, 2023, 83 (07)
  • [30] KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity
    Xu Liu
    Department of Gastroenterology
    Department of Experimental Hematology
    Hepatobiliary&PancreaticDiseasesInternational, 2011, 10 (02) : 201 - 208
12345